LFTD Partners (LIFD) AI Stock Analysis

• Market Cap: $2.96M
• Dividend Yield: N/A
• Average Volume (3M): 1.38K
• Price to Earnings (P/E): 54.1
• Beta (1Y): 0.54
• Revenue Growth: -12.70%
• EPS Growth: N/A
• Country: US
• Employees: 148
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 14,822,678
• 10 Day Avg. Volume: 3,614
• 30 Day Avg. Volume: 1,380
• PEG Ratio: 0.02
• Price to Book (P/B): 0.19
• Price to Sales (P/S): 0.19
• P/FCF Ratio: -5.69
• Enterprise Value/Market Cap: 1.43
• Enterprise Value/Revenue: 0.11
• Enterprise Value/Gross Profit: 0.36
• Enterprise Value/Ebitda: 4.39
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: $0.22 ▼(-26.00% Downside)
• Action: Reiterated Date: 12/31/25
• Date: Action: Reiterated 12/31/25

The score is primarily held back by weak profitability and significant cash flow challenges, despite a comparatively stable balance sheet. Technically, the stock is in a downtrend below major moving averages with soft momentum, and valuation risk is elevated due to a high P/E and no dividend yield support.

Positive Factors

Diversified holding model across cannabis, consumer products, e-commerce

A diversified holding structure gives LFTD durable downside protection and optionality: multiple end-markets reduce single-market exposure, enable cross-brand distribution and cost sharing, and support roll-up or bolt-on M&A strategies to drive steady portfolio growth.

Relatively stable balance sheet with healthy equity ratio

Moderate leverage and a healthy equity ratio provide financial flexibility over the medium term. This stability supports operational continuity, capacity for strategic investments or acquisitions, and a buffer against industry cyclicality without immediate solvency pressure.

Multi-channel revenue model: direct-to-consumer and wholesale

Having both e-commerce and wholesale channels supports scalable distribution and margin optimization. Direct channels improve customer data and unit economics while wholesale expands reach; together they create durable revenue diversification and resilience to single-channel disruption.

Negative Factors

Negative operating and free cash flow

Sustained negative operating and free cash flow weakens the firm's ability to self-fund growth, maintain inventory, or invest in marketing and R&D. Over months this increases reliance on external financing, raises execution risk, and can constrain strategic flexibility.

Declining profitability and negative net margin

Eroding gross and negative net margins indicate the business struggles to convert sales into sustainable profits. Persisting margin pressure undermines long-term reinvestment capacity, lowers returns on capital, and challenges the viability of expansion or acquisition plans.

Inconsistent and declining revenue growth

Variable and negative revenue trends reduce predictability for cash flows and planning. Over 2–6 months this impairs economies of scale, complicates cost allocation, and weakens negotiating leverage with suppliers and distributors, making sustainable margin recovery harder.

LFTD Partners Business Overview & Revenue Model

Company Description

LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired Sales Corp. and changed its name to LFTD Partners Inc. in September 2021. LFTD Partners Inc. was incorporated in 1986 and is headquartered in Jacksonville, Florida.

How the Company Makes Money

LFTD Partners generates revenue primarily through its ownership and operation of various subsidiaries in the cannabis and consumer products sectors. The company earns money by selling products directly to consumers through e-commerce channels, as well as via wholesale distribution to retailers. Key revenue streams include sales from branded cannabis products, wellness items, and other consumer goods. Additionally, LIFD may engage in strategic partnerships with other businesses to enhance its market reach and product offerings, further contributing to its earnings. The company also focuses on optimizing operational efficiencies and cost management to maximize profit margins across its various business units.

LFTD Partners Financial Statement Overview

Summary

Financials are pressured by declining profitability and inconsistent revenue trends (income statement score 45) and significant cash flow weakness with negative operating and free cash flow (cash flow score 40). The balance sheet is comparatively steadier with moderate leverage and a healthy equity ratio (balance sheet score 65), but reduced ROE points to weaker shareholder return generation.

Income Statement

LFTD Partners has experienced significant volatility in its revenue growth, with a notable decline in recent years. The gross profit margin has decreased over time, indicating potential cost management issues. The net profit margin is negative in the latest TTM period, reflecting challenges in achieving profitability. Overall, the income statement shows a mixed performance with declining profitability and inconsistent revenue growth.

Balance Sheet

The company's balance sheet reflects a stable debt-to-equity ratio, indicating moderate leverage. However, the return on equity has significantly decreased, suggesting reduced efficiency in generating returns for shareholders. The equity ratio remains healthy, indicating a solid capital structure. Overall, the balance sheet is stable but shows reduced profitability.

Cash Flow

LFTD Partners faces challenges in cash flow generation, with negative operating and free cash flows in the latest TTM period. The free cash flow growth rate is negative, indicating declining cash generation capabilities. The operating cash flow to net income ratio is also negative, highlighting inefficiencies in converting income into cash. Overall, the cash flow statement reflects significant cash management challenges.

Breakdown	TTM	Dec 2024	Mar 2024	Dec 2022	Mar 2022	Dec 2020
Income Statement
Total Revenue	36.99M	37.33M	51.61M	57.42M	31.66M	5.34M
Gross Profit	11.68M	12.75M	19.70M	20.99M	15.94M	1.94M
EBITDA	964.48K	-1.50M	3.35M	10.31M	7.40M	-1.45M
Net Income	63.45K	-1.86M	2.16M	7.20M	5.80M	-1.53M
Balance Sheet
Total Assets	44.94M	47.32M	51.35M	41.13M	39.42M	27.83M
Cash, Cash Equivalents and Short-Term Investments	1.92M	2.15M	4.36M	3.72M	1.60M	439.08K
Total Debt	3.33M	4.51M	4.49M	1.86M	1.34M	3.91M
Total Liabilities	7.39M	9.81M	12.53M	6.59M	11.96M	6.21M
Stockholders Equity	37.56M	37.50M	38.82M	34.54M	27.46M	21.62M
Cash Flow
Free Cash Flow	-197.81K	-1.27M	-150.74K	2.12M	5.25M	-408.17K
Operating Cash Flow	-107.72K	-960.07K	638.92K	3.04M	5.62M	-338.04K
Investing Cash Flow	-86.05K	-479.57K	-2.52M	-916.12K	-446.65K	-3.51M
Financing Cash Flow	-1.06M	-770.95K	3.70M	-193.42K	-4.01M	-98.00K

LFTD Partners Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Negative. The current price of 0.3 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.23, and above the 200-day MA of 0.29, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 34.65 is Neutral, neither overbought nor oversold. The STOCH value of 31.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LIFD.

LFTD Partners Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
YCBD	48 Neutral	$9.80M	-0.42	-44.42%	―	-1.50%	80.17%
IXHL	47 Neutral	$98.18M	-0.36	-114.52%	―	-86.05%	24.17%
LIFD	45 Neutral	$2.96M	54.05	-2.05%	―	-12.70%	―
IMCC	40 Underperform	$4.20M	-1.02	-93.87%	―	-0.74%	81.49%